Health Canada instructed companies to stop distributing ranitidine drugs in Canada in September 2019 while it assessed the risk of impurity and probable carcinogen called NDMA (N-nitrosodimethylamine) detected in some drugs.
Why were ranitidine medications like Zantac recalled by Health Canada?
The companies have since recalled products from the Canadian market because they contained or potentially contained high levels of NDMA. Ranitidine is the active ingredient in these medications (such as brand name Zantac) that treat stomach problems, ulcers, heartburn, and gastroesophageal reflux disease (GERD).
Zantac cancer link
Studies have shown that NDMA could cause stomach, bladder, and liver cancer and with one in four Canadians suffering from heartburn or indigestion, it is likely that the devastating effects of the impurity will be far-reaching. Despite scientific evidence showing that Zantac exposed users to unacceptable levels of NDMA, none of the manufacturers disclosed this risk.
Can I sue a pharmaceutical company through a law firm?
In the United States, there is currently multi-district litigation against Sanofi and Boehringer Ingelheim, the manufacturers of Zantac. Class action law firm Shamis and Gentile, P.A. is providing legal services for similar legal action. If you have taken Zantac and would like more information about possible compensation or punitive damages that you may be entitled to, contact the attorneys at Shamis and Gentile, P.A.
Plaintiffs in this class action lawsuit have claimed that NDMA was not listed as a component of the ranitidine medication and cancer was not mentioned as a potential risk. Zantac users are now saying that they are suffering from serious mental distress along with an increased risk of developing cancer due to potential long-term exposure to this potential carcinogen.
There is no need to suffer alone in silence; contact the attorneys at Shamis and Gentile, P.A. today, and be a part of this national class-action lawsuit.